Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.53 |
| ▸ | HPGD | P15428 | 2/20 | 0.53 |
| ▸ | MEN1 | O00255 | 2/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.53 |
| ▸ | HTT | P42858 | 2/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.53 |
| ▸ | TSPO | P30536 | 3/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | EDNRA | P25101 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | ABL1 | P00519 | 1/20 | 0.45 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.45 |
| ▸ | BCR | P11274 | 1/20 | 0.45 |
| ▸ | ATM | Q13315 | 2/20 | 0.44 |
| ▸ | KDR | P35968 | 1/20 | 0.43 |
| ▸ | OXTR | P30559 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15435752 | 0.97 | MAPT (0.55) | MAPTALDH1A1L3MBTL1KDM4EHPGD | |
| SCHEMBL12628267 | 0.97 | MAPT (0.55) | MAPTALDH1A1L3MBTL1KDM4EHPGD | |
| SCHEMBL12628264 | 0.97 | MAPT (0.55) | MAPTALDH1A1L3MBTL1KDM4EHPGD | |
| SCHEMBL17998131 | 0.95 | MAPT (0.48) | MAPTALDH1A1L3MBTL1KDM4EHPGD | |
| SCHEMBL15502668 | 0.93 | TSPO (0.48) | MAPTALDH1A1L3MBTL1KDM4EHPGD | |
| SCHEMBL16171615 | 0.93 | MAPT (0.51) | MAPTALDH1A1L3MBTL1KDM4EHPGD | |
| SCHEMBL15502788 | 0.92 | TSPO (0.49) | MAPTALDH1A1L3MBTL1KDM4EHPGD | |
| SCHEMBL16171511 | 0.92 | MAPT (0.50) | MAPTALDH1A1L3MBTL1KDM4EHPGD | |
| SCHEMBL15435800 | 0.92 | MAPT (0.50) | MAPTALDH1A1L3MBTL1KDM4EHPGD | |
| SCHEMBL16171589 | 0.90 | KDM4E (0.59) | MAPTALDH1A1L3MBTL1KDM4EHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7816021-B2 | Carbazole-based compound and organic light-emitting device including organic layer including the carbazole-based compound | SAMSUNG MOBILE DISPLAY CO., LTD. (KR) | 2010-10-19 | — | — | US | disclosed |
| US-7816021-B2 | Carbazole-based compound and organic light-emitting device including organic layer including the carbazole-based compound | SAMSUNG MOBILE DISPLAY CO., LTD. (KR) | 2010-10-19 | — | — | US | disclosed |
| US-20080174237-A1 | CARBAZOLE-BASED COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING ORGANIC LAYER INCLUDING THE CARBAZOLE-BASED COMPOUND | SAMSUNG SDI CO., LTD. (KR) | 2008-07-24 | — | — | US | disclosed |
| US-20080174237-A1 | CARBAZOLE-BASED COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING ORGANIC LAYER INCLUDING THE CARBAZOLE-BASED COMPOUND | SAMSUNG SDI CO., LTD. (KR) | 2008-07-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080174237-A1 | CARBAZOLE-BASED COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING ORGANIC LAYER INCLUDING THE CARBAZOLE-BASED COMPOUND | IK, POU5F1, OXA1L | MAPT 2776/4885ALDH1A1 1807/4885L3MBTL1 542/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.